Alcohol Consumption Emerges as a Key Risk Factor for Buccal Cancer in India
December 24, 2025
Brand Name :
Sulpade, Dogmatyl, Dolmatil
Synonyms :
sulpiride
Class :
Antipsychotics
Dosage Forms & Strengths
Tablets
200 mg
400 mg
Syrup
200mg/5ml
400-800mg is given orally daily in two divided doses in the morning and evening. maximum dose: 1200 mg twice a day. Negative symptoms: 200 to 400 mg twice a day. Positive and negative symptoms: 400 to 600 mg twice a day
Dosage Forms & Strengths
Tablets
200 mg
400 mg
Syrup
200mg/5ml
14 to 18 years: 200-400mg is given twice a day
12 to 18 years: 100-400mg is given twice a day
2 to 12 years: 50-400mg is given twice a day
Refer to the adult dosing regimen
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
sulpiride: they may diminish the serum concentration of antacids
sulpiride: they may diminish the serum concentration of antacids
sulpiride: they may diminish the serum concentration of antacids
sulpiride: they may diminish the serum concentration of antacids
sulpiride: they may diminish the serum concentration of antacids
sulpiride: they may diminish the serum concentration of antacids
sulpiride: they may diminish the serum concentration of antacids
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
may have an increasingly adverse effect when combined with sulpiride
may have an increasingly adverse effect when combined with sulpiride
may have an increasingly adverse effect when combined with sulpiride
may have an increasingly adverse effect when combined with sulpiride
may have an increasingly adverse effect when combined with sulpiride
it decreases the efficacy of antiparkinson agents
it decreases the efficacy of antiparkinson agents
it decreases the efficacy of antiparkinson agents
it decreases the efficacy of antiparkinson agents
it decreases the efficacy of antiparkinson agents
The Therapeutic efficacy of quinagolide might be reduced
The potential for increased toxicity of Sulpiride could be amplified by the presence of antipsychotic agents
The potential for increased toxicity of Sulpiride could be amplified by the presence of antipsychotic agents
The potential for increased toxicity of Sulpiride could be amplified by the presence of antipsychotic agents
The potential for increased toxicity of Sulpiride could be amplified by the presence of antipsychotic agents
The potential for increased toxicity of Sulpiride could be amplified by the presence of antipsychotic agents
the efficacy of dopamine agonists will be decreased when sulpride is used in combination
the efficacy of dopamine agonists will be decreased when sulpride is used in combination
the efficacy of dopamine agonists will be decreased when sulpride is used in combination
the efficacy of dopamine agonists will be decreased when sulpride is used in combination
the efficacy of dopamine agonists will be decreased when sulpride is used in combination
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the hypotensive effect of beta-blockers
may enhance the hypotensive effect of beta-blockers
may enhance the hypotensive effect of beta-blockers
may enhance the hypotensive effect of beta-blockers
may enhance the hypotensive effect of beta-blockers
may reduce the therapeutic effect of anti-Parkinson drugs
may reduce the therapeutic effect of anti-Parkinson drugs
may reduce the therapeutic effect of anti-Parkinson drugs
may reduce the therapeutic effect of anti-Parkinson drugs
may reduce the therapeutic effect of anti-Parkinson drugs
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may diminish the therapeutic effect of the drug
may diminish the therapeutic effect of the drug
may diminish the therapeutic effect of the drug
may diminish the therapeutic effect of the drug
may diminish the therapeutic effect of the drug
may diminish the therapeutic effect of the drug
may diminish the therapeutic effect of the drug
may diminish the therapeutic effect of the drug
may diminish the therapeutic effect of the drug
May enhance the hypotensive effect of beta-Blockers
May enhance the hypotensive effect of beta-Blockers
May enhance the hypotensive effect of beta-Blockers
May enhance the hypotensive effect of beta-Blockers
May enhance the hypotensive effect of beta-Blockers
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may decrease the absorption of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
Actions and spectrum:
Action:
Spectrum of Use:
Frequency not defined
Agitation
Akathisia
Blurred vision
Catatonia
Confusion
Delirium
Diarrhoea
Drowsiness
Dyskinesia
ECG changes
Galactorrhoea
Haemolytic anaemia
Hyperglycaemia
Hyperthermia
Hypokinesia
Hypothermia
Jaundice
Maculopapular rash
Oligomenorrhoea
Amenorrhoea
Breast enlargement
Cardiac arrest
Constipation
Convulsions
Deep vein thrombosis
Depression
Difficulty in micturition
Dry mouth
Dystonia
Erectile dysfunction
Gynaecomastia
Hepatitis
Black Box Warning:
There were no specific black box warnings associated with sulpiride.
Contraindication/Caution:
Contraindication:
Caution:
Comorbidities:
Pregnancy consideration: pregnancy category: not assigned
Lactation: excreted into human milk: unknown
Pregnancy category:
Pharmacology:
sulpiride is an antipsychotic medication with a unique pharmacological profile. It primarily acts as a selective dopamine D2 receptor antagonist in the brain, which means it blocks the effects of the neurotransmitter dopamine on these receptors. By doing so, sulpiride helps regulate dopamine levels and function in the central nervous system, particularly in areas of the brain associated with psychosis and mood regulation.
sulpiride also prefers certain subtypes of D2 receptors, such as D2 and D3 receptors, which contributes to its unique clinical effects. The medication is used to treat a range of psychiatric and neurological disorders, including schizophrenia, schizoaffective disorder, bipolar disorder, and certain mood disturbances.
Pharmacodynamics:
Pharmacokinetics:
Absorption
sulpiride is commonly administered orally in the form of tablets or capsules. It is well absorbed from the gastrointestinal tract, with peak blood levels occurring about 2 to 6 hours after ingestion.
Distribution
sulpiride could cross blood-brain barrier, allowing it to reach its target sites in the central nervous system, where it acts on dopamine receptors.
Metabolism
The metabolism of sulpiride involves cytochrome P450 enzymes, particularly CYP2D6 and CYP3A4, which are responsible for various drug-metabolizing reactions. Genetic variations in these enzymes can influence the metabolism of sulpiride and the potential for drug interactions.
Elimination and excretion
The primary route of excretion for sulpiride and its metabolites is through the kidneys, where they are eliminated in the urine. Unchanged sulpiride and its sulfoxide metabolite are excreted in the urine.
Administration:
Patient information leaflet
Generic Name: sulpiride
Pronounced: (suhl-PEER-ide)
Why do we use sulpiride?
sulpiride is prescribed to manage the symptoms of schizophrenia. It can help reduce or control positive symptoms of the disorder, such as delusions, hallucinations, and thought disturbances. This medication can be used to treat schizoaffective disorder, a condition characterized by a combination of mood disorder and schizophrenia symptoms.
It helps alleviate both psychotic and mood-related symptoms in such cases. sulpiride is sometimes used in the management of bipolar disorder, particularly during manic or hypomanic episodes. It can help stabilize mood and control manic symptoms.